Tag: Radiopharmaceuticals

Rusatom Healthcare and MedInvestGroup set up a production of radiopharmaceuticals

Rusatom Healthcare JSC (integrator of Rosatom State Corporation radiation technologies) and MedInvestGroup LLC, a part of the Pharmstandard group, signed a cooperation agreement.

VEB supported new radiopharmaceuticals production in Russia

Russian "Bank for Development and Foreign Economic Affairs" opened financing for a project to organize the production of radiopharmaceuticals.

Rosatom suggests to develop Russian radiopharmaceutical based on Yttrium-90

Specialists suggest developing the first Russian radiopharmaceutical based on the radioactive isotope Yttrium-90 for the treatment of cancer.

CivaTech Oncology developed novel bio-absorbable radiation treatment

Physicians are now able to successfully implant a new bio-absorbable, internal radiation treatment known as CivaSheet® to treat a patient with recurrent lung cancer.

Isotopia and Bar-Ilan University intend to develop a new radioactive marker

The Israeli Isotopia Company, in collaboration with Prof. Rachela Popovtzer of Bar-Ilan University's Faculty of Engineering, is conducting a joint study to develop a radioactive marker for the detection of cancer.

IRM plans to launch manufacturing of its first radiopharmaceuticals in 2019

A Nuclear Medicine Center may be soon established in the Ural region as a result of efforts by the specialists of the Institute of Reactor Materials (an enterprise of Scientific Division of Rosatom State Corporation).

Endocyte and ITM signed a long-term global supply agreement

Endocyte and ITM Isotopen Technologien München AG (ITM) announced that ITM´s subsidiary and Endocyte have signed a long-term global supply agreement for the highly purified, no-carrier-added Lutetium-177 (177Lu) EndolucinBeta.

New cyclotron in St. Petersburg will help to develop a novel biomarker

radiopharmaceutical drug
Russia’s first new generation cyclotron (accelerator of particles) intended for manufacturing pharmaceuticals for cancer diagnosis was installed at Dr. Berezin Medical Institute (MIBS) in St. Petersburg.

Telix Pharmaceutical sets up research partnership with INSERM and ARRONAX

Telix Pharmaceuticals announced a research partnership with the French National Institute of Health and Medical Research and the “Accelerator for Research in Radiochemistry and Oncology at Nantes Atlantic”.

Actinium Pharmaceuticals and Astellas will collaborate on a radiopharmaceutical

Actinium Pharmaceuticals entered into a research and option agreement with Astellas Pharma to develop Actinium-225 Radio-Conjugates (ARCs) using its Actinium Warhead Enabling (AWE) Platform Technology.

Kaluga is expected to complete its program for radiopharmaceuticals in two years

radiopharmaceutical drug
Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor expects that the region needs 2 years to complete its import substitution program for radiopharmaceuticals.

National PET-Technology network covers nine Russian regions

PET-Technology, the national network of nuclear medicine centers established with the RUSNANO support, opened its 10th center in Samara. The investments in Samara center amounted to more than 410 million rubles.

UrFU researchers will create methods for targeted delivery of cancer drugs

The scientists at the Cyclotron Center for Nuclear Medicine of the Ural Federal University will design new methods for targeted delivery of drugs to the malignant tumor location

Russian scientists receive award for unique R&D in the area of oncology

The award of the Government of the Russian Federation was given for the development, manufacturing and implementation of Russian radioactive sources for contact radiation therapy

Telix Pharmaceuticals will transfer its technology to Japan

Telix Pharmaceuticals, a biopharmaceutical company focused on the development of targeted radiopharmaceuticals or “molecularly-targeted radiation”, announced the establishment Telix Pharmaceuticals Japan

USU will develop technology for manufacturing radiopharmaceuticals

radiopharmaceutical drug
A center for personalized nuclear medicine was opened on the basis of the Ulyanovsk State University. The new center will ensure the development of technology for manufacturing the radiopharmaceuticals.